Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 124

1.

Tolerance Biomarkers in Liver Transplantation: Independent External Validation of the Predictive Strength of SENP6 and FEM1C Gene Expression.

Pérez-Sanz F, Revilla-Nuin B, Marínez-Alarcón L, Herrero JI, Ramírez P, Pons JA, Baroja-Mazo A.

Transplantation. 2019 Jan 30. doi: 10.1097/TP.0000000000002587. [Epub ahead of print]

PMID:
30720688
2.

Group Psychotherapy Could Improve Depression in Cirrhotic Patients on the Liver Transplant Waiting List.

Febrero B, Ramírez P, Martínez-Alarcón L, Abete C, Galera M, Ríos A, Robles-Martínez R, Ramírez-Pino PM, Almela J, Ramis G, Pons JA, Parrilla P.

Transplant Proc. 2019 Jan - Feb;51(1):28-32. doi: 10.1016/j.transproceed.2018.02.206. Epub 2018 Jun 28.

PMID:
30685106
3.

Liver Transplantation for Fulminant Hepatic Failure Due to Heat Stroke: A Case Report.

Martínez-Insfran LA, Alconchel F, Ramírez P, Cascales-Campos PA, Carbonell G, Barona L, Pons JA, Sánchez-Bueno F, Robles-Campos R, Parrilla P.

Transplant Proc. 2019 Jan - Feb;51(1):87-89. doi: 10.1016/j.transproceed.2018.03.137. Epub 2018 Jun 30.

PMID:
30661899
4.

Orthotopic Liver Transplantation With Elderly Donors (Over 80 Years of Age): A Prospective Evaluation.

Cascales-Campos PA, Ramírez P, González-Sánchez MR, Alconchel F, Martínez-Insfran LA, Sánchez-Bueno F, Robles R, Pons JA, Vargas Á, Sanmartín J, Royo-Villanova M, Parrilla P.

Transplant Proc. 2018 Dec;50(10):3594-3600. doi: 10.1016/j.transproceed.2018.08.005. Epub 2018 Aug 9.

PMID:
30577243
5.

Quality of Life and Group Psychological Intervention in Patients With Cirrhosis on Liver Transplant Waiting List.

Febrero B, Ramírez P, Martínez-Alarcón L, Abete C, Galera M, Ríos A, Robles-Martínez R, Ramírez-Pino PM, Almela J, Ramis G, Pons JA, Parrilla P.

Transplant Proc. 2018 Nov;50(9):2626-2629. doi: 10.1016/j.transproceed.2018.04.013. Epub 2018 Apr 11.

PMID:
30401363
6.

Extracellular adenosine reversibly inhibits the activation of human regulatory T cells and negatively influences the achievement of the operational tolerance in liver transplantation.

Baroja-Mazo A, Revilla-Nuin B, de Bejar Á, Martínez-Alarcón L, Herrero JI, El-Tayeb A, Müller CE, Aparicio P, Pelegrín P, Pons JA.

Am J Transplant. 2019 Jan;19(1):48-61. doi: 10.1111/ajt.15023. Epub 2018 Aug 31.

PMID:
30019408
7.

VI consensus document by the Spanish Liver Transplantation Society.

Pardo F, Pons JA, Castells L, Colmenero J, Gómez MÁ, Lladó L, Pérez B, Prieto M, Briceño J.

Gastroenterol Hepatol. 2018 Jun - Jul;41(6):406-421. doi: 10.1016/j.gastrohep.2018.05.012. Epub 2018 Jun 1. English, Spanish.

PMID:
29866511
8.

VI consensus document by the Spanish Liver Transplantation Society.

Pardo F, Pons JA, Castells L, Colmenero J, Gómez MÁ, Lladó L, Pérez B, Prieto M, Briceño J.

Cir Esp. 2018 Jun - Jul;96(6):326-341. doi: 10.1016/j.ciresp.2017.12.013. English, Spanish.

PMID:
29776591
9.

Donors Older Than 75 Years Do Not Influence the Appearance of Biliary Complications After Liver Transplantation.

González-Sánchez MR, Cascales-Campos PA, López-Espín JJ, Febrero B, Pons JA, Vargas Acosta A, Ros J, Sánchez-Bueno F, Robles R, Sáenz L, Ramírez P, Parilla P.

Transplant Proc. 2018 Mar;50(2):640-643. doi: 10.1016/j.transproceed.2017.11.048.

PMID:
29579875
10.

Long-term Survival and Evolution of the Kidney Function for Liver Transplant Patients Who Required Postoperative Dialysis.

Rosique F, Cabezuelo JB, Ferreras D, González-Sánchez MR, Ros J, Pons JA, Cascales-Campos PA, Sánchez-Bueno F, Robles R, Ramírez P, Parrilla P.

Transplant Proc. 2018 Mar;50(2):634-636. doi: 10.1016/j.transproceed.2017.11.053.

PMID:
29579873
11.

Liver Transplantation in Patients With Hepatocellular Carcinoma Outside the Milan Criteria After Downstaging: Is It Worth It?

Cascales-Campos P, Martinez-Insfran LA, Ramirez P, Ferreras D, Gonzalez-Sanchez MR, Sanchez-Bueno F, Robles R, Pons JA, Capel A, Parrilla P.

Transplant Proc. 2018 Mar;50(2):591-594. doi: 10.1016/j.transproceed.2017.09.063.

PMID:
29579861
12.

In vitro intracellular IFNγ, IL-17 and IL-10 producing T cells correlates with the occurrence of post-transplant opportunistic infection in liver and kidney recipients.

Boix F, Llorente S, Eguía J, Gonzalez-Martinez G, Alfaro R, Galián JA, Campillo JA, Moya-Quiles MR, Minguela A, Pons JA, Muro M.

World J Transplant. 2018 Feb 24;8(1):23-37. doi: 10.5500/wjt.v8.i1.23.

13.

Extracellular ATP Activates the NLRP3 Inflammasome and Is an Early Danger Signal of Skin Allograft Rejection.

Amores-Iniesta J, Barberà-Cremades M, Martínez CM, Pons JA, Revilla-Nuin B, Martínez-Alarcón L, Di Virgilio F, Parrilla P, Baroja-Mazo A, Pelegrín P.

Cell Rep. 2017 Dec 19;21(12):3414-3426. doi: 10.1016/j.celrep.2017.11.079.

14.

Influence of donor liver CYP3A4*20 loss-of-function genotype on tacrolimus pharmacokinetics in transplanted patients.

Gómez-Bravo MA, Apellaniz-Ruiz M, Salcedo M, Fondevila C, Suarez F, Castellote J, Rufian S, Pons JA, Bilbao I, Alamo JM, Millán O, Brunet M, Rodríguez-Antona C.

Pharmacogenet Genomics. 2018 Feb;28(2):41-48. doi: 10.1097/FPC.0000000000000321.

PMID:
29256966
15.

Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study.

Rodríguez M, Pascasio JM, Fraga E, Fuentes J, Prieto M, Sánchez-Antolín G, Calleja JL, Molina E, García-Buey ML, Blanco MÁ, Salmerón J, Bonet ML, Pons JA, González JM, Casado MÁ, Jorquera F; TENOSIMP-B Research Group.

World J Gastroenterol. 2017 Nov 7;23(41):7459-7469. doi: 10.3748/wjg.v23.i41.7459.

16.

Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study.

Salcedo M, Prieto M, Castells L, Pascasio JM, Montero Alvarez JL, Fernández I, Sánchez-Antolín G, González-Diéguez L, García-Gonzalez M, Otero A, Lorente S, Espinosa MD, Testillano M, González A, Castellote J, Casafont F, Londoño MC, Pons JA, Molina Pérez E, Cuervas-Mons V, Pascual S, Herrero JI, Narváez I, Vinaixa C, Llaneras J, Sousa JM, Bañares R.

Transpl Int. 2017 Oct;30(10):1041-1050. doi: 10.1111/tri.12999. Epub 2017 Jul 27.

17.

Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients.

Aguiar D, Martínez-Urbistondo D, Baroja-Mazo A, de la Mata M, Rodríguez-Perálvarez M, Rubín A, Puchades L, Serrano T, Montero J, Cuadrado A, Casafont F, Salcedo M, Rincón D, Pons JA, Herrero JI.

Ann Transplant. 2017 May 2;22:265-275.

18.

CD28 biomarker quantification and expression level profiles in CD4+ T-lymphocytes in solid organ transplantation.

Boix F, Bolarín JM, Mrowiec A, Eguía J, Gonzalez-Martinez G, de la Peña J, Galian JA, Alfaro R, Moya-Quiles MR, Legaz I, Campillo JA, Ramírez P, García-Alonso A, Pons JA, Sánchez-Bueno F, Minguela A, Llorente S, Muro M.

Transpl Immunol. 2017 Jun;42:9-17. doi: 10.1016/j.trim.2017.04.001. Epub 2017 Apr 6.

PMID:
28392336
19.

Differential profile of activated regulatory T cell subsets and microRNAs in tolerant liver transplant recipients.

Revilla-Nuin B, de Bejar Á, Martínez-Alarcón L, Herrero JI, Martínez-Cáceres CM, Ramírez P, Baroja-Mazo A, Pons JA.

Liver Transpl. 2017 Jul;23(7):933-945. doi: 10.1002/lt.24691.

20.

Pretransplant CD28 Biomarker (Levels of Expression and Quantification of Molecules per Cell) in Peripheral CD4+ T Cells Predicts Acute Rejection Episodes in Liver and Kidney Recipients.

Boix F, Bolarín JM, Eguía J, Gonzalez-Martinez G, De La Peña J, Galian JA, Hernández-Martínez AM, Moya-Quiles MR, Legaz I, Campillo JA, Ramirez P, Sanchez-Bueno F, García-Alonso AM, Pons JA, Minguela A, Llorente S, Muro M.

Transplant Proc. 2016 Nov;48(9):2987-2989. doi: 10.1016/j.transproceed.2016.09.028.

PMID:
27932126

Supplemental Content

Loading ...
Support Center